Comparison of 3D and 2D tumor models reveals enhanced HER2 activation in 3D associated with an increased response to trastuzumab.
Oncogene. 2009 Jan 22;28(3):461-8. doi: 10.1038/onc.2008.394. Epub 2008 Nov 3.
Oncogene. 2009.
PMID: 18978815